ATE357926T1 - Verwendung von mhc-xenoantigenes zur herstellung eines arzneimittels für eine therapeutische behandlung von krebs - Google Patents

Verwendung von mhc-xenoantigenes zur herstellung eines arzneimittels für eine therapeutische behandlung von krebs

Info

Publication number: ATE357926T1
Authority: AT; Austria
Prior art keywords: cancer; xenoantigenes; mhc; producing; therapeutic treatment
Prior art date: 1994-08-05

Application number

AT95904529T

Other languages

English (en)

Inventor

Angela Turiano

Original Assignee

Applied Res Systems N V

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-08-05

Filing date

1994-12-22

Publication date

2007-04-15

1994-12-22 Application filed by Applied Res Systems N V filed Critical Applied Res Systems N V

2007-04-15 Application granted granted Critical

2007-04-15 Publication of ATE357926T1 publication Critical patent/ATE357926T1/de

Links

206010028980 Neoplasm Diseases 0.000 title 1
201000011510 cancer Diseases 0.000 title 1
229940126601 medicinal product Drugs 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1
BHNQPLPANNDEGL-UHFFFAOYSA-N 2-(4-octylphenoxy)ethanol Chemical compound CCCCCCCCC1=CC=C(OCCO)C=C1 BHNQPLPANNDEGL-UHFFFAOYSA-N 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000000605 extraction Methods 0.000 abstract 1
QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 abstract 1
210000000987 immune system Anatomy 0.000 abstract 1
238000011275 oncology therapy Methods 0.000 abstract 1
230000000638 stimulation Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Medicinal Chemistry (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Cell Biology (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Compounds Of Unknown Constitution (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AT95904529T 1994-08-05 1994-12-22 Verwendung von mhc-xenoantigenes zur herstellung eines arzneimittels für eine therapeutische behandlung von krebs ATE357926T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ITMI941713A IT1274592B (it)	1994-08-05	1994-08-05	Composizione farmaceutica per la terapia tumorale contenente xenoantigeni

Publications (1)

Publication Number	Publication Date
ATE357926T1 true ATE357926T1 (de)	2007-04-15

Family

ID=11369459

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95904529T ATE357926T1 (de)	1994-08-05	1994-12-22	Verwendung von mhc-xenoantigenes zur herstellung eines arzneimittels für eine therapeutische behandlung von krebs

Country Status (9)

Country	Link
US (2)	US20030045453A1 (de)
EP (1)	EP0773789B1 (de)
AT (1)	ATE357926T1 (de)
DE (1)	DE69434946T2 (de)
DK (1)	DK0773789T3 (de)
ES (1)	ES2285702T3 (de)
IT (1)	IT1274592B (de)
PT (1)	PT773789E (de)
WO (1)	WO1996004005A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2172322C1 (ru)	1999-12-27	2001-08-20	Энтофарм Ко., Лтд.	Аллофероны-иммуномодулирующие пептиды

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9201023D0 (en) *	1992-01-17	1992-03-11	Medical Res Council	Vaccines
JPH05246889A (ja) *	1992-03-05	1993-09-24	Seitai Chiyousetsu Kenkyusho:Kk	制癌方法および制癌剤
EP0569678A3 (de) *	1992-03-13	1994-10-26	Yeda Res & Dev	Mit MHC-Genen doppelt transfizierte Zellen als Impfstoffe zur Immunoprevention von Tumormetastasen.
GB9214871D0 (en) *	1992-07-13	1992-08-26	Medical Res Council	Vaccines
WO1994013320A1 (en) *	1992-12-17	1994-06-23	Subramaniam Sriram	Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease

1994
- 1994-08-05 IT ITMI941713A patent/IT1274592B/it active IP Right Grant
- 1994-12-22 AT AT95904529T patent/ATE357926T1/de not_active IP Right Cessation
- 1994-12-22 US US08/817,595 patent/US20030045453A1/en not_active Abandoned
- 1994-12-22 WO PCT/EP1994/004290 patent/WO1996004005A1/en not_active Ceased
- 1994-12-22 EP EP95904529A patent/EP0773789B1/de not_active Expired - Lifetime
- 1994-12-22 PT PT95904529T patent/PT773789E/pt unknown
- 1994-12-22 DE DE69434946T patent/DE69434946T2/de not_active Expired - Fee Related
- 1994-12-22 ES ES95904529T patent/ES2285702T3/es not_active Expired - Lifetime
- 1994-12-22 DK DK95904529T patent/DK0773789T3/da active
2005
- 2005-04-18 US US11/107,782 patent/US20050238653A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ITMI941713A1 (it)	1996-02-05
US20050238653A1 (en)	2005-10-27
DE69434946D1 (de)	2007-05-10
ITMI941713A0 (it)	1994-08-05
EP0773789B1 (de)	2007-03-28
IT1274592B (it)	1997-07-18
DE69434946T2 (de)	2007-12-06
US20030045453A1 (en)	2003-03-06
DK0773789T3 (da)	2007-05-29
PT773789E (pt)	2007-04-30
EP0773789A1 (de)	1997-05-21
ES2285702T3 (es)	2007-11-16
WO1996004005A1 (en)	1996-02-15

Similar Documents

Publication	Publication Date	Title
ATE330593T1 (de)	2006-07-15	Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen
ES2000428A4 (es)	1988-03-01	Procedimiento para producir un medicamento para el tratamiento de la enfermedad de alzheimer, que contiene galantamina, y dispositivo medico correspondiente.
ATE332702T1 (de)	2006-08-15	Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen
ATE213411T1 (de)	2002-03-15	Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
DE69333775D1 (de)	2005-04-21	Synthetische katalytische freie radikalfänger, verwendbar als antioxidantien zur prävention und therapie von krankheiten
ATE213164T1 (de)	2002-02-15	Verwendung von nona- und dekapeptiden zur herstellung eines arzneimittels zur bekämpfung von aids
ES2190093T3 (es)	2003-07-16	Uso de un producto proteico de neurturina para prevenir y tratar la perddida de audicion.
DE60003010D1 (de)	2003-07-03	Verwendung eines serenoa repens extraktes zur herstellung eines arzneimittels zur behandlung von krebserkrankungen der prostata
DE69636085D1 (de)	2006-06-08	Verwendung von gamma-Linolensäure oder Dihomogammalinolensäure zur Herstellung eines Medikaments zur Behandlung von Huntington's Chorea
PT923293E (pt)	2005-03-31	Tratamento da diarreia
IL130931A0 (en)	2001-01-28	Small molecules useful in the treatment of inflammatory disease
NO974767D0 (no)	1997-10-15	Anvendelse av glianeurotrof faktor (GDNF) til behandling av hörselssykdommer
ATE197670T1 (de)	2000-12-15	Parenterales busulfan zur behandlung von malignen krankheiten
ATE218873T1 (de)	2002-06-15	Verwendung von wasser mit verringertem deuterium- gehalt zur herstellung von hygienischen und kosmetischen präparaten
DE69631478D1 (de)	2004-03-11	Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
DE69826023D1 (de)	2004-10-07	Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome
ATE274349T1 (de)	2004-09-15	Verwendung von fruktan zur herstellung eines arzneimittels zur vorbeugung und behandlung von dickdarmkrebs
ATE79254T1 (de)	1992-08-15	Die verwendung von d-fenfluramin zur herstellung von arzneimitteln, zur behandlung von depressionen.
DE3768150D1 (de)	1991-04-04	Verwendung eines 1,3-oxazolidin-2-on-derivates zur herstellung eines arzneimittels zur behandlung von ischaemie.
DE69434946D1 (de)	2007-05-10	Verwendung von MHC-Xenoantigenes zur Herstellung eines Arzneimittels für eine therapeutische Behandlung von Krebs
ATE192929T1 (de)	2000-06-15	Verwendung von dimeticon zur herstellung eines arzneimittels zur behandlung von aphthen und stomatitis
DE69621786D1 (de)	2002-07-18	Aminotetralinderivat zur behandlung von herzkreislauferkrankung
DE68905657D1 (de)	1993-05-06	Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
DE69424415D1 (de)	2000-06-15	Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
ATE332706T1 (de)	2006-08-15	Verwendung von hyaluronidase zur herstellung eines arzneimittels zur behandlung von entzündungen

Legal Events

Date

Code

Title

Description

2007-09-15

UEP

Publication of translation of european patent specification

Ref document number: 0773789

Country of ref document: EP

2010-09-15

REN

Ceased due to non-payment of the annual fee